A systematic review of the predictive value of (18)FDG-PET in esophageal and esophagogastric junction cancer after neoadjuvant chemoradiation on the survival outcome stratification. (Q38196733)

From Wikidata

Jump to navigation Jump to search

scientific article published on 18 March 2014

Language	Label	Description	Also known as
English	A systematic review of the predictive value of (18)FDG-PET in esophageal and esophagogastric junction cancer after neoadjuvant chemoradiation on the survival outcome stratification.	scientific article published on 18 March 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638928%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

1 reference

Europe PubMed Central

A systematic review of the predictive value of (18)FDG-PET in esophageal and esophagogastric junction cancer after neoadjuvant chemoradiation on the survival outcome stratification (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638928%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

chemoradiotherapy

0 references

systematic review

1 reference

based on heuristic

inferred from title

Claude Bertrand

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638928%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

author name string

Pascaline Schollaert

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638928%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Ralph Crott

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638928%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Lionel D'Hondt

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638928%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Thierry Vander Borght

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638928%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Bruno Krug

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638928%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

publication date

18 March 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638928%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Journal of Gastrointestinal Surgery

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638928%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638928%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638928%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

894-905

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24638928%20AND%20SRC:MED&resulttype=core&format=json

10 March 2020

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

18F-FDG PET and 18F-FDG PET/CT for assessing response to therapy in esophageal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Metabolic positron emission tomography imaging in cancer detection and therapy response

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Positron-emission tomography and assessment of cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Evidence-based guideline recommendations on the use of positron emission tomography imaging in oesophageal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Role of ¹⁸F 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies.

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

PET imaging for prediction of response to therapy and outcome in oesophageal carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Prediction of tumor response to neoadjuvant therapy in patients with esophageal cancer with use of 18F FDG PET: a systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Gastrointestinal tract malignancies and positron emission tomography: an overview

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Positron emission tomography for monitoring response to neoadjuvant therapy in patients with oesophageal and gastro-oesophageal junction carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Role of PET/PET CT in the staging and restaging of thoracic oesophageal cancer and gastro-oesophageal cancer: a literature review

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Early repeated 18F-FDG PET scans during neoadjuvant chemoradiation fail to predict histopathologic response or survival benefit in adenocarcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

FDG-PET/CT tumor segmentation-derived indices of metabolic activity to assess response to neoadjuvant therapy and progression-free survival in esophageal cancer: correlation with histopathology results.

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Outcomes of patients with esophageal cancer staged with [¹⁸F]fluorodeoxyglucose positron emission tomography (FDG-PET): can postchemoradiotherapy FDG-PET predict the utility of resection?

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Positron emission tomographic scanning predicts survival after induction chemotherapy for esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Metabolic tumor width parameters as determined on PET/CT predict disease-free survival and treatment response in squamous cell carcinoma of the esophagus

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Assessment of treatment response and recurrence in esophageal carcinoma based on tumor length and standardized uptake value on positron emission tomography-computed tomography.

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Meta-analysis and subgroups.

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Bivariate random-effects meta-analysis and the estimation of between-study correlation

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

An evaluation of bivariate random-effects meta-analysis for the joint synthesis of two correlated outcomes.

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Whole body 18F-FDG PET predicts progression free and overall survival in squamous cell carcinoma of the esophagus: results of a prospective trial

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial.

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Significant clinical impact and prognostic stratification provided by FDG-PET in the staging of oesophageal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Positron emission tomography for assessment of the response to induction radiochemotherapy in locally advanced oesophageal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

The higher the decrease in the standardized uptake value of positron emission tomography after chemoradiation, the better the survival of patients with gastroesophageal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Locally advanced esophageal adenocarcinoma: response to neoadjuvant chemotherapy and survival predicted by ([18F])FDG-PET/CT.

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Value of complete metabolic response by (18)F-fluorodeoxyglucose-positron emission tomography in oesophageal cancer for prediction of pathologic response and survival after preoperative chemoradiotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Prediction of tumor response by FDG-PET: comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junction.

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Prediction of the outcome of definitive chemoradiation by decrease in F-18 FDG uptake in nonsurgical esophageal squamous cell cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

(18)F-FDG PET-guided salvage neoadjuvant radiochemotherapy of adenocarcinoma of the esophagogastric junction: the MUNICON II trial.

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

[18F]-Fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemoradiation in esophageal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Association of the VEGF 936C>T polymorphism with FDG uptake, clinical, histopathological, and metabolic response in patients with adenocarcinomas of the esophagogastric junction.

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Use of (18)F-fluorodeoxyglucose-positron emission tomography to evaluate responses to neo-adjuvant chemotherapy for primary tumor and lymph node metastasis in esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

The standardized uptake value of 18-fluorodeoxyglucose positron emission tomography after chemoradiation and clinical outcome in patients with localized gastroesophageal carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction.

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Critical role of surgery in patients with gastroesophageal carcinoma with a poor prognosis after chemoradiation as defined by positron emission tomography

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Induction chemotherapy in Barrett cancer: influence on surgical risk and outcome

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

A systematic review classifies sources of bias and variation in diagnostic test accuracy studies

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Sources of variation and bias in studies of diagnostic accuracy: a systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Use of methodological standards in diagnostic test research. Getting better but still not good.

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Exploring sources of heterogeneity in systematic reviews of diagnostic tests

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Evaluation of diagnostic procedures

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Evaluation of early response to concomitant chemoradiotherapy by interim 18F-FDG PET/CT imaging in patients with locally advanced oesophageal carcinomas

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Prognostic significance of SUV on PET/CT in patients with localised oesophagogastric junction cancer receiving neoadjuvant chemotherapy/chemoradiation:a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Downstaging of T or N Predicts Long-Term Survival After Preoperative Chemotherapy and Radical Resection for Esophageal Carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS11605-014-2488-2

21 January 2018

Phase 2 trial of induction and concurrent chemoradiotherapy with weekly irinotecan and cisplatin followed by surgery for esophageal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24638928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/24638928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans

1 reference

https://pubmed.ncbi.nlm.nih.gov/24638928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Utility of response evaluation to neo-adjuvant chemotherapy by (18)F-fluorodeoxyglucose-positron emission tomography in locally advanced esophageal squamous cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24638928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of fludeoxyglucose F 18 uptake in posttreatment positron emission tomography as a significant predictor of survival after subsequent surgery in multimodality treatment for patients with locally advanced esophageal squamous cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/24638928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predicting the effects of chemoradiotherapy for squamous cell carcinoma of the esophagus by induction chemotherapy response assessed by positron emission tomography: toward PET-response-guided selection of chemoradiotherapy or esophagectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24638928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Postchemoradiotherapy positron emission tomography predicts pathologic response and survival in patients with esophageal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/24638928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38196733&oldid=2201391708"